Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Sandra R Bacman1, Walter G Bradley, Carlos T Moraes

  • 1Department of Neurology, University of Miami, Miller School of Medicine, FL, USA.

Molecular Neurobiology
|April 11, 2006
PubMed
Summary

Mitochondrial dysfunction plays a key role in amyotrophic lateral sclerosis (ALS), acting as both a trigger and target. This cellular damage is a critical step in motor neuron death, impacting disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopaminergic neurons preferentially accumulate mtDNA rearrangements.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Persistence of large mtDNA rearrangements linked to premature aging in Pol γ exonuclease-deficient mice.

Nucleic acids research·2026
Same author

Generation and characterization of the TRE-TNFR2 transgenic mouse for cell-specific and timed (over)expression of tumor necrosis factor receptor 2.

Cytokine·2026
Same author

The Mitochondrial Blueprint of Skin Aging: From Damage Signals to Dermatologic Interventions.

Aging and disease·2026
Same author

Transient muscle expression of mitoARCUS in mice leads to sustained reductions in pathogenic mtDNA and reduces fatigability.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

mtDNA base editing: Mind the gap.

Molecular cell·2025

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Mitochondrial abnormalities are frequently reported in amyotrophic lateral sclerosis (ALS).
  • The precise role of mitochondrial dysfunction in ALS pathogenesis remains unclear.
  • Studies indicate activation of the mitochondrial apoptotic pathway in ALS models.

Purpose of the Study:

  • To investigate the role of mitochondrial dysfunction in the onset and progression of amyotrophic lateral sclerosis (ALS).
  • To determine if mitochondrial changes precede or result from cellular viability loss in ALS.
  • To synthesize evidence for mitochondrial involvement in both familial and sporadic ALS.

Main Methods:

  • Review of current scientific literature on mitochondrial dysfunction and ALS.

Related Experiment Videos

  • Analysis of studies involving mouse models of ALS with mutant superoxide dismutase 1.
  • Examination of evidence for cytochrome-c release and mitochondrial swelling in ALS.

    • Main Results:

    • The intrinsic mitochondrial apoptotic program is activated in the central nervous system of ALS mouse models.
    • Observed mitochondrial changes include cytochrome-c release and swelling.
    • It remains uncertain whether these mitochondrial changes initiate or follow cellular viability decline.

    Conclusions:

    • Mitochondria are likely both a trigger and a target in amyotrophic lateral sclerosis (ALS).
    • Mitochondrial demise is a critical event leading to motor neuron death in ALS.
    • Understanding mitochondrial involvement is crucial for ALS therapeutic strategies.